These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


134 related items for PubMed ID: 14465574

  • 1. Some effects of tranylcypromine and trifluoperazine on electrocortical activity (EEG activation).
    LING GM.
    Can Psychiatr Assoc J; 1962; 7(Suppl)():44-54. PubMed ID: 14465574
    [No Abstract] [Full Text] [Related]

  • 2. Neuropharmacology of tranylcypromine and trifluoperazine.
    TEDESCHI RE, TEDESCHI DH, FELLOWS EJ.
    Can Psychiatr Assoc J; 1962; 7(Suppl)():55-9. PubMed ID: 13920073
    [No Abstract] [Full Text] [Related]

  • 3. The effect of tranylcypromine-trifluoperazine in the treatment of depressive states.
    BRAM G.
    Can Psychiatr Assoc J; 1962; 7(Suppl)():84-6. PubMed ID: 13872435
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The use of tranylcypromine and trifluoperazine in the management of coexisting depression and anxiety.
    GODDARD ES.
    Can Psychiatr Assoc J; 1962; 7(Suppl)():87-90. PubMed ID: 13899397
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Combined use of tranylcypromine and trifluoperazine in ambulatory treatment of patients with agitated depressions: Preliminary evaluation.
    LESSE S.
    N Y State J Med; 1961 Jun 01; 61():1898-903. PubMed ID: 13761180
    [No Abstract] [Full Text] [Related]

  • 12. Combined tranlcypromine and trifluoperazine therapy in general medicine.
    LEWIS RA.
    Can Psychiatr Assoc J; 1962 Jun 01; 7(Suppl)():74-6. PubMed ID: 14464901
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of psychoactive drugs on in vivo metabolism of 14C-histamine in mouse brain.
    Schayer RW, Reilly MA.
    Arch Int Pharmacodyn Ther; 1973 May 01; 203(1):123-9. PubMed ID: 4725329
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Tranylcypromine (parnate) a new monoamine oxidase inhibitor.
    LEMERE F.
    Am J Psychiatry; 1960 Sep 01; 117():249. PubMed ID: 14415582
    [No Abstract] [Full Text] [Related]

  • 18. [BIOLOGICAL AND PHARMACOLOGICAL ACTIVITY OF MONOAMINE OXIDASE INHIBITORS: THE ASSOCIATION OF TRANYLCYPROMINE AND TRIFLUOPERAZINE IN THE THERAPY OF DEPRESSIVE SYNDROMES].
    GRATTAROLA FR, ROSSO G, ROVERA GG.
    Clin Ter; 1963 Sep 15; 26():406-30. PubMed ID: 14091908
    [No Abstract] [Full Text] [Related]

  • 19. Tranylcypromine and the extrapyramidal syndromes.
    BARBEAU A, DUCHASTEL Y.
    Can Psychiatr Assoc J; 1962 Sep 15; 7(Suppl)():91-5. PubMed ID: 13864822
    [No Abstract] [Full Text] [Related]

  • 20. Tranylcypromine on fifty ambulatory psychiatric patients.
    DARLING HF.
    Dis Nerv Syst; 1962 Feb 15; 23():91-2. PubMed ID: 13883578
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.